{"data":[{"accessionNo":"0000902219-26-000248","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001582313","issuerName":"Xenon Pharmaceuticals Inc.","ticker":"XENE","cusip":"98420N105","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Wellington Group Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":1425492,"percentOfClass":1.5,"filedAt":"2026-08-13"},{"accessionNo":"0000902219-26-000248","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001582313","issuerName":"Xenon Pharmaceuticals Inc.","ticker":"XENE","cusip":"98420N105","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Wellington Management Group LLP","reportingCik":null,"personType":"HC","sharesOwned":1425492,"percentOfClass":1.5,"filedAt":"2026-08-13"},{"accessionNo":"0000902219-26-000248","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001582313","issuerName":"Xenon Pharmaceuticals Inc.","ticker":"XENE","cusip":"98420N105","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Wellington Investment Advisors Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":1425492,"percentOfClass":1.5,"filedAt":"2026-08-13"},{"accessionNo":"0000315066-26-002245","formType":"SCHEDULE 13G/A","amendmentNo":8,"issuerCik":"0001582313","issuerName":"XENON PHARMACEUTICALS INC","ticker":"XENE","cusip":"98420N105","securityClass":"COMMON STOCK","eventDate":"2026-07-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":9959795.17,"percentOfClass":10.3,"filedAt":"2026-08-07"},{"accessionNo":"0000315066-26-002245","formType":"SCHEDULE 13G/A","amendmentNo":8,"issuerCik":"0001582313","issuerName":"XENON PHARMACEUTICALS INC","ticker":"XENE","cusip":"98420N105","securityClass":"COMMON STOCK","eventDate":"2026-07-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":9959795.17,"percentOfClass":10.3,"filedAt":"2026-08-07"},{"accessionNo":"0000315066-26-002171","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001582313","issuerName":"XENON PHARMACEUTICALS INC","ticker":"XENE","cusip":"98420N105","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":9599498,"percentOfClass":9.9,"filedAt":"2026-08-06"},{"accessionNo":"0000315066-26-002171","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001582313","issuerName":"XENON PHARMACEUTICALS INC","ticker":"XENE","cusip":"98420N105","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":9599498,"percentOfClass":9.9,"filedAt":"2026-08-06"},{"accessionNo":"0000902664-26-002464","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001582313","issuerName":"Xenon Pharmaceuticals, Inc.","ticker":"XENE","cusip":"98420N105","securityClass":"Common Shares, no par value per share","eventDate":"2026-03-31","reportingPerson":"Behzad Aghazadeh","reportingCik":null,"personType":"HC,IN","sharesOwned":5777777,"percentOfClass":6.26,"filedAt":"2026-05-15"},{"accessionNo":"0000902664-26-002464","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001582313","issuerName":"Xenon Pharmaceuticals, Inc.","ticker":"XENE","cusip":"98420N105","securityClass":"Common Shares, no par value per share","eventDate":"2026-03-31","reportingPerson":"Avoro Capital Advisors LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":5777777,"percentOfClass":6.26,"filedAt":"2026-05-15"},{"accessionNo":"0000938206-26-000027","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001582313","issuerName":"Xenon Pharmaceuticals Inc.","ticker":"XENE","cusip":"98420N105","securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"DRIEHAUS CAPITAL MANAGEMENT LLC","reportingCik":null,"personType":"IA","sharesOwned":4491653,"percentOfClass":4.87,"filedAt":"2026-05-15"},{"accessionNo":"0001274173-26-000118","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001582313","issuerName":"XENON PHARMACEUTICALS INC.","ticker":"XENE","cusip":"98420N105","securityClass":"Common Shares","eventDate":"2026-03-31","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"HC","sharesOwned":4175982,"percentOfClass":4.5,"filedAt":"2026-05-15"},{"accessionNo":"0000902219-26-000084","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001582313","issuerName":"Xenon Pharmaceuticals Inc.","ticker":"XENE","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Management Group LLP","reportingCik":null,"personType":"HC","sharesOwned":4764779,"percentOfClass":6.2,"filedAt":"2026-02-10"},{"accessionNo":"0000902219-26-000084","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001582313","issuerName":"Xenon Pharmaceuticals Inc.","ticker":"XENE","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Group Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":4764779,"percentOfClass":6.2,"filedAt":"2026-02-10"},{"accessionNo":"0000902219-26-000084","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001582313","issuerName":"Xenon Pharmaceuticals Inc.","ticker":"XENE","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Investment Advisors Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":4764779,"percentOfClass":6.2,"filedAt":"2026-02-10"},{"accessionNo":"0000902219-26-000084","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001582313","issuerName":"Xenon Pharmaceuticals Inc.","ticker":"XENE","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Management Company LLP","reportingCik":null,"personType":"IA","sharesOwned":4764779,"percentOfClass":6,"filedAt":"2026-02-10"},{"accessionNo":"0001274173-25-000274","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001582313","issuerName":"XENON PHARMACEUTICALS INC.","ticker":"XENE","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"IA,HC","sharesOwned":3943885,"percentOfClass":5.1,"filedAt":"2025-11-14"}],"updatedAt":"2026-10-14T20:17:28.979Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}